2004
DOI: 10.1002/elsc.200406127
|View full text |Cite
|
Sign up to set email alerts
|

New Developments in Chemical Engineering for the Production of Drug Substances

Abstract: The pharmaceutical industry is moving towards a profitability gap between increasing costs and decreasing prices. Finally, management has understood that mergers and acquisitions, high throughput screening, and biotechnology alone will not save the companies' earnings. Therefore, classical approaches like the optimization of production technologies for drug substances, that might help to increase profitability, are receiving increasing attention. This paper shows how the combination of innovative components wi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
36
0
3

Year Published

2006
2006
2019
2019

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 39 publications
(39 citation statements)
references
References 36 publications
0
36
0
3
Order By: Relevance
“…The chains have grown rapidly in recent years due to market rivalry for new, safe and effective drugs with short production times (Behr et al, 2004;Gebauer, Kickuth & Friedli, 2009;Melton, 2005). The market demand for variety in pharmaceutical produce requires greater flexibility, smaller orders and a more varied mix of products within the manufacturing process (Gilmore & Smith, 1996).…”
Section: Research Contextmentioning
confidence: 99%
“…The chains have grown rapidly in recent years due to market rivalry for new, safe and effective drugs with short production times (Behr et al, 2004;Gebauer, Kickuth & Friedli, 2009;Melton, 2005). The market demand for variety in pharmaceutical produce requires greater flexibility, smaller orders and a more varied mix of products within the manufacturing process (Gilmore & Smith, 1996).…”
Section: Research Contextmentioning
confidence: 99%
“…replicating small units working in parallel. 1,10,14 However, fluid distribution and parallelization of microscale units is not such a straightforward task as is often claimed, 20 and according to Kockmann et al, 21 it should even be kept as a last option. Furthermore, practical problems such as blockages from solids in suspension still form a main limitation for microreaction technology.…”
Section: Introductionmentioning
confidence: 99%
“…1,2 Fierce competition and increasing time and cost related to drug discovery and development have motivated a change in the business strategy of pharmaceutical companies, increasingly emphasizing cost reduction and shorter time to market. 3,4 These objectives must be met through an improvement of the efficiency and sustainability of all processes related to the discovery, development and long-term manufacturing of drug products.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Die integrierte MiniplantTechnologie, die sich der Miniplant-Technik, Modellierung und Simulation bedient und in der chemischen Verfahrenstechnik Stand der Technik ist, ermöglicht die Untersuchung von verschalteten Verfahrensstufen oder kompletten Prozessen zur beschleunigten Verfahrensentwicklung [1,2] [5], Mustermengen zu produzieren [5], den Einfluss von akkumulierenden Nebenprodukten aufgrund von Rückführungen zu untersuchen [6], die Stabilität der verwendeten Werkstoffe zu prü-fen [7], sind weitere wichtige Anwendungsgebiete von Miniplant-Anlagen. Neben dem Einsatz als Forschungs-und Versuchsanlage können Miniplants für die Kleinmengenproduktion genutzt werden [8]. Bei der Produktion toxischer Stoffe bieten kontinuierliche Miniplant-Anlagen gegenüber absatzweise betriebenen Produktionsanlagen den Vorteil, das Gefahrenpotenzial zu verringern [9].…”
Section: Introductionunclassified